#DGX (Quest Diagnostics Incorporated). Směnný kurz a online grafy.

Quest Diagnostics Inc. About company

Quest Diagnostics Inc. is an American clinical laboratory founded in 1967. It offers access to diagnostic testing services for cancer as well as cardiovascular and infectious diseases, including coronavirus, etc.

Nowadays, the company is focused on:

• diagnostic services (conducting research and providing data analysis);
• diagnostic solutions (risk assessment services for life and health insurance).

This is the largest provider of such services in the United States. The company's market capitalization stands at $14,379 billion. Its revenues for 2021 amounted to $10,788 million and its net profit to $1,995 million.

Quest Diagnostics Inc. shares and factors impacting their price

Quest Diagnostics Inc. stock has been traded on the New York Stock Exchange since 1996 under the DGX ticker.

Currently, its shares are estimated at $122-$126. During the year, the stock price fluctuated in the range of $120 - $175.

The company consistently pays dividends to shareholders in the amount of $2.1 per share annually. The average payment totals 1.93% and it is constantly growing.

You should pay attention to the following factors when trading Quest Diagnostics’ shares:

• News related to the activity of its main competitor - Laboratory Corporation of America Holdings as well as a number of smaller regional laboratories;
• Advantages of the company: long operation history, significant market share, high quality of services, and innovations in the field of service provision;
• Strategic agreements with medical institutions, governmental agencies, and other medical retailers.